AVAVA MIRIA General Use

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
AVAVA, Inc.
Study ID
NCT06868615
Status
Recruiting
Apply to this trial

Conditions

  • Acne
  • Acne Scars - Mixed Atrophic and Hypertrophic
  • Pigment; Lesion
  • Scars
  • Skin Texture Disorder
  • Wrinkle

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • AVAVA — DEVICE
    1550nm Non-Ablative Fractional Laser

Study Details

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Key Dates

Start date
Sep 11, 2024
Status verified
Mar 2025
Primary completion
Dec 30, 2027
Completion
Dec 30, 2027

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Subjects treated with the AVAVA Device

Primary Outcome Measure

Completion of Post-Treatment Subject Questionnaire [ Time Frame: Immediate Post-Treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AVAVA, Inc.WalthamMassachusetts02451
Alexander Denis
[email protected]
617-693-6669

Find similar trials in Waltham, MA

By research site
AVAVA, Inc.· Waltham, MA

Related Studies